Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to... see more

TSXV:BTI - Post Discussion

Bioasis Technologies Inc. > RE:RE:RE:RE:RE: "excellent" progress on early-stage pipeline
View:
Post by hcontrol on Aug 14, 2020 2:09pm

RE:RE:RE:RE:RE: "excellent" progress on early-stage pipeline

I think the higher probability would be to have all of our pipeline programs advanced far enough so when we reach Clinical trials with 001 that we sell just the 001 program (even for 1 billion, so roughly $10 a share US) and keep the rest of the company.  Another option would be to become a trust bank so to speak, were all Pharma's can license our technology but never aquire it.  We would become a perpetual licensing machine. 

Either way, yes we make boat loads of money.  From where we are now it seems like big shoes to fill but if we ever start looking like we can fill them, look out...
Comment by Sniper007 on Aug 14, 2020 3:09pm
"Another option would be to become a trust bank so to speak, were all Pharma's can license our technology but never acquire it.  We would become a perpetual licensing machine." Agreed hcontrol. That's what I was eluding to when I said we become "the dealer". Whether it's realistic or not, it scares me to think of only 1 pharma owning the technology. It could ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities